GlassScriptPhysician profile
Matthew A Spiegel
NPI 1245684133
$2,296.35
in general payments reported to CMS, 2019-2025
12 companies · $516 in 2025
The $516 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $363 · 2022: $431 · 2023: $357 · 2024: $630 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,502.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $804.92 | 2021-2025 | Intellis Adaptivestim, Rialto Si Fusion System, Inceptiv |
| Abbott Laboratories | $576.84 | 2021-2024 | Proclaim |
| Globus Medical, INC. | $290.21 | 2025 | Senza |
| Boston Scientific Corporation | $198.18 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $157.80 | 2021-2023 | Sprint Pns System |
| Saluda Medical Americas, INC. | $104.35 | 2024 | Evoke |
| Nevro Corp. | $76.49 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $22.74 | 2022 | |
| Forte Bio-Pharma LLC | $22.64 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.55 | 2022 | |
| Collegium Pharmaceutical, INC. | $14.49 | 2023 | Belbuca |
| Abbvie INC. | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Spiegel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.